ANAB

Anaptysbio Stock Analysis

AI Rating

Great
  • Quality6/10
  • Growth↑ 7/10
  • Momentum↑ 9/10
Anaptysbio sales and earnings growth
ANAB Growth
Good
  • Revenue Y/Y↑ 196.42%
  • EPS Y/Y↑ 54.93%
  • FCF Y/Y↓ -40.56%
Anaptysbio gross and profit margin trends
ANAB Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ -49.90%
  • ROIC↓ -13.70%
Anaptysbio net debt vs free cash flow
ANAB Risk
Great
  • Debt / Equity↓ -11.8
  • Debt / FCF↓ 1.6
  • Interest coverage↓ NA

Anaptysbio stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗